Rendocan Visits Cannabis Europa Conference 2019 in Paris

The Rendocan team has visited the highly anticipated Cannabis Europa conference in Paris, France. “There is obviously a paradigm shift going on in Europe as more and more countries are allowing for the prescription of cannabis-based medicines. It is however important that good quality research and clinical trials can fill in the missing gaps in our knowledge and understanding of the huge potential of the cannabis plant in modern medicine.” Says Joris Vanvinckenroye, CEO of Rendocan.  
Close Menu